| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M113.461848 |
| P8608 | Fatcat ID | release_cwiczlzbnfgehpmnq4fhkvqmcy |
| P932 | PMC publication ID | 3829441 |
| P698 | PubMed publication ID | 23990468 |
| P5875 | ResearchGate publication ID | 256290877 |
| P50 | author | Paul H Anderson | Q56233362 |
| Gerald J Atkins | Q56233363 | ||
| P2093 | author name string | Tsuyoshi Sato | |
| Masafumi Tsujimoto | |||
| Peter C Gray | |||
| Yasushi Okazaki | |||
| Masahito Matsumoto | |||
| Naoki Kato | |||
| Aya Fukuda | |||
| Koji Hisatake | |||
| David M Findlay | |||
| Shigehiro Katayama | |||
| Tatsuo Suda | |||
| Masakazu Kogawa | |||
| Tetsuya Yoda | |||
| Yukiko Kanesaki-Yatsuka | |||
| Seiki Wada | |||
| Yuichiro Enoki | |||
| P2860 | cites work | Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1 | Q22306225 |
| Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1 | Q24300916 | ||
| Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 | ||
| Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I) | Q24322489 | ||
| Transcriptional repression by Pax5 (BSAP) through interaction with corepressors of the Groucho family | Q24594237 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification | Q24603266 | ||
| Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families | Q28137631 | ||
| The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts | Q28140929 | ||
| Bone resorption by osteoclasts | Q28145169 | ||
| RANK-L and RANK: T cells, bone loss, and mammalian evolution | Q28203468 | ||
| Getting your Pax straight: Pax proteins in development and disease | Q28212326 | ||
| PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects | Q28240060 | ||
| Dysgenesis of cephalic neural crest derivatives in Pax7-/- mutant mice | Q28278850 | ||
| Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system | Q28283972 | ||
| Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis | Q28295246 | ||
| Pax2 contributes to inner ear patterning and optic nerve trajectory | Q28511597 | ||
| Pax3 functions at a nodal point in melanocyte stem cell differentiation | Q28587774 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| Antagonistic effects of Grg6 and Groucho/TLE on the transcription repression activity of brain factor 1/FoxG1 and cortical neuron differentiation | Q28590799 | ||
| Decreased neural crest stem cell expansion is responsible for the conotruncal heart defects within the splotch (Sp(2H))/Pax3 mouse mutant | Q28594842 | ||
| Mouse small eye results from mutations in a paired-like homeobox-containing gene | Q29617930 | ||
| Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts | Q29618116 | ||
| Pax9-deficient mice lack pharyngeal pouch derivatives and teeth and exhibit craniofacial and limb abnormalities. | Q32024327 | ||
| The activation of the rat insulin gene II by BETA2 and PDX-1 in rat insulinoma cells is repressed by Pax6 | Q33637181 | ||
| Pax6 represses androgen receptor-mediated transactivation by inhibiting recruitment of the coactivator SPBP. | Q34026199 | ||
| The role of Pax-1 in axial skeleton development. | Q34329886 | ||
| A regulatory loop involving PAX6, MITF, and WNT signaling controls retinal pigment epithelium development | Q34335517 | ||
| Pax genes and organogenesis. | Q34439185 | ||
| Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro | Q34459310 | ||
| Reaching a genetic and molecular understanding of skeletal development | Q34611297 | ||
| Requirement for NF-kappaB in osteoclast and B-cell development | Q35199657 | ||
| Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation | Q35848573 | ||
| PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts. | Q36105975 | ||
| Crosstalk between the EGFR and other signalling pathways at the level of the global transcriptional corepressor Groucho/TLE. | Q36409971 | ||
| Identification of a Pax paired domain recognition sequence and evidence for DNA-dependent conformational changes | Q38310017 | ||
| Activation of the transcription factor ISGF3 by interferon-gamma | Q38322204 | ||
| Groucho homologue Grg5 interacts with the transcription factor Runx2-Cbfa1 and modulates its activity during postnatal growth in mice | Q38340348 | ||
| The Groucho/TLE/Grg family of transcriptional co-repressors | Q38610837 | ||
| The E2A-HLF oncoprotein activates Groucho-related genes and suppresses Runx1. | Q39460862 | ||
| IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB | Q39946703 | ||
| Groucho suppresses Pax2 transactivation by inhibition of JNK-mediated phosphorylation | Q39962419 | ||
| Corecruitment of the Grg4 repressor by PU.1 is critical for Pax5-mediated repression of B-cell-specific genes | Q40099900 | ||
| Pax5-deficient mice exhibit early onset osteopenia with increased osteoclast progenitors | Q40489394 | ||
| Regulation of receptor activator of NF-kappaB ligand-induced tartrate-resistant acid phosphatase gene expression by PU.1-interacting protein/interferon regulatory factor-4. Synergism with microphthalmia transcription factor | Q40796459 | ||
| Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor | Q40838540 | ||
| Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. | Q41121255 | ||
| Genetic and physical interactions between Microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation. | Q42826784 | ||
| Complex regulatory element within the gammaE- and gammaF-crystallin enhancers mediates Pax6 regulation and is required for induction by retinoic acid. | Q43954150 | ||
| Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development | Q44055107 | ||
| Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein | Q44500763 | ||
| Characterization of three novel members of the zebrafish Pax2/5/8 family: dependency of Pax5 and Pax8 expression on the Pax2.1 (noi) function | Q47073232 | ||
| Groucho proteins: transcriptional corepressors for specific subsets of DNA-binding transcription factors in vertebrates and invertebrates | Q47899785 | ||
| Conservation of a large protein domain in the segmentation gene paired and in functionally related genes of Drosophila. | Q48354415 | ||
| Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. | Q50943562 | ||
| IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL | Q51027178 | ||
| Darier disease, multiple bone cysts, and aniridia due to double de novo heterozygous mutations in ATP2A2 and PAX6. | Q51930227 | ||
| Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. | Q52192178 | ||
| RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β | Q57675150 | ||
| Bone and haematopoietic defects in mice lacking c-fos | Q58326969 | ||
| T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ | Q59064307 | ||
| Pax6 is required for differentiation of glucagon-producing α-cells in mouse pancreas | Q59070691 | ||
| Pleiotropic effects of a null mutation in the c-fos proto-oncogene | Q62555352 | ||
| Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL) | Q73907464 | ||
| P433 | issue | 43 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | NF-κB | Q411114 |
| P304 | page(s) | 31299-31312 | |
| P577 | publication date | 2013-08-29 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-κB ligand (RANKL)-induced osteoclast differentiation | |
| P478 | volume | 288 |
| Q58728809 | A Metabolomics Study on the Bone Protective Effects of a Lignan-Rich Fraction From Sambucus Williamsii Ramulus in Aged Rats |
| Q37671291 | Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo. |
| Q37082335 | Donepezil prevents RANK-induced bone loss via inhibition of osteoclast differentiation by downregulating acetylcholinesterase |
| Q47595585 | Gα12 regulates osteoclastogenesis by modulating NFATc1 expression |
| Q47140180 | Kaempferide Prevents Titanium Particle Induced Osteolysis by Suppressing JNK Activation during Osteoclast Formation |
| Q49907069 | Paeoniflorin ameliorates collagen-induced arthritis via suppressing NF-κB signaling pathway in osteoclast differentiation. |
| Q33890247 | Suppression of PAX6 promotes cell proliferation and inhibits apoptosis in human retinoblastoma cells |
Search more.